Pharma-Bio Serv (PBSV) Projected to Post Earnings on Friday

Pharma-Bio Serv (OTCMKTS:PBSV) is expected to be posting its quarterly earnings results on Friday, June 13th. Analysts expect Pharma-Bio Serv to post earnings of $0.03 per share and revenue of $3.00 million for the quarter.

Pharma-Bio Serv (OTCMKTS:PBSV) last announced its quarterly earnings results on Monday, March 17th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.02 by $0.35. The business had revenue of $2.47 million for the quarter, compared to analyst estimates of $2.70 million. Pharma-Bio Serv had a negative return on equity of 5.61% and a negative net margin of 8.18%.

Pharma-Bio Serv Trading Down 14.5%

Shares of PBSV opened at $0.50 on Wednesday. The firm has a market cap of $11.47 million, a P/E ratio of -16.67 and a beta of 0.68. The company’s 50-day moving average price is $0.47 and its 200 day moving average price is $0.51. Pharma-Bio Serv has a 12-month low of $0.31 and a 12-month high of $0.69.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.